Autopsy report · NCT02217202

Study of AQUACEL™ Ag Surgical Cover Dressing Following Total Knee Replacement

“Funding withdrawn before ethical approval granted”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Golden Jubilee National Hospital

Sponsor type

Government (non-US federal)

Conditions

Osteoarthritis

Interventions

Aquacel Ag dressing

Participants

0

Trials that died the same way

• Walnuts and Glucose Variability
  “Funding withdrawn” (78% match in meaning)
• Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer
  “funding was withdrawn” (78% match in meaning)
• Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma
  “Funding withdrawn by sponsor” (78% match in meaning)
• Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Tributyrin Supplementation
  “Withdrawal of funding” (75% match in meaning)
• Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
  “Withdrawal of funding support” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.